
|Articles|December 1, 2007
Supplements and Featured Publications
- Decision Maker News - Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia an
- Volume 12
- Issue 1 - Decis
Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Single-Dose Oral Antibiotic Zoliflodacin Treats Drug-Resistant Gonorrhea
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
5













































